![Timothy Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Kelly
Chief Tech/Sci/R&D Officer at
ABIVAX
Net worth: 112 613 $ as of 31/08/2026
Profile
Mr. Timothy P.
Kelly is a Chief Technical Officer at Abivax SA. Mr. Kelly was previously employed as a Chief Technology Officer by Caribou Biosciences, Inc., a Chairman & Chief Executive Officer by Oxford Biomedica Solutions LLC, a Chief Operating Officer by Homology Medicines, Inc., a Head-Technical Operations by Sarepta Therapeutics, Inc., a Head-Technical Operations by Shire Plc, a Head-Technical Operations by UCB SA, and a Senior Director-International Operations by Biogen Idec, Inc. He received his undergraduate degree from United States Air Force Academy and an MBA from Troy University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/02/2026 | 73,125 ( 0.07% ) | 112 613 $ | 31/08/2026 |
Timothy Kelly active positions
| Companies | Position | Start |
|---|---|---|
| ABIVAX | Chief Tech/Sci/R&D Officer | 21/09/2026 |
Former positions of Timothy Kelly
| Companies | Position | End |
|---|---|---|
Oxford Biomedica Solutions LLC
 Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Chief Executive Officer | 01/07/2023 |
| Q32 BIO INC. | Chief Operating Officer | 10/03/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2017 |
| SHIRE | Corporate Officer/Principal | 01/01/2017 |
| UCB | Corporate Officer/Principal | 01/01/2009 |
Training of Timothy Kelly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
United States Air Force Academy
 United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Troy University
 Troy University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Producer Manufacturing |
- Stock Market
- Insiders
- Timothy Kelly
